BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 14666722)

  • 1. Tumor-associated macrophage (TAM) infiltration in gastric cancer.
    Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Okumura H; Matsumoto M; Miyazono F; Hokita S; Aikou T
    Anticancer Res; 2003; 23(5A):4079-83. PubMed ID: 14666722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients.
    Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Suzuki N; Inoue M; Soma G; Nagasue N
    Anticancer Res; 2003; 23(6D):5015-22. PubMed ID: 14981961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.
    Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Ohno Y; Suzuki N; Inoue M; Soma G; Nagasue N
    Anticancer Res; 2005; 25(1B):463-70. PubMed ID: 15816613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer.
    Nakayama Y; Nagashima N; Minagawa N; Inoue Y; Katsuki T; Onitsuka K; Sako T; Hirata K; Nagata N; Itoh H
    Anticancer Res; 2002; 22(6C):4291-6. PubMed ID: 12553072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer.
    Ohno S; Ohno Y; Suzuki N; Kamei T; Koike K; Inagawa H; Kohchi C; Soma G; Inoue M
    Anticancer Res; 2004; 24(5C):3335-42. PubMed ID: 15515429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer.
    Shah CA; Allison KH; Garcia RL; Gray HJ; Goff BA; Swisher EM
    Gynecol Oncol; 2008 May; 109(2):215-9. PubMed ID: 18314181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
    Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y
    Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of tumor-associated macrophages on progression and prognosis of nasopharyngeal carcinoma].
    Peng J; Ding T; Zheng LM; Shao JY
    Ai Zheng; 2006 Nov; 25(11):1340-5. PubMed ID: 17094898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD3 zeta expression of regional lymph node and peripheral blood lymphocytes in gastric cancer.
    Ishigami S; Natsugoe S; Miyazono F; Tokuda K; Nakajo A; Matsumoto M; Okumura H; Nakashima S; Hokita S; Maruyama I; Aikou T
    Anticancer Res; 2004; 24(3b):2123-6. PubMed ID: 15274412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-G expression in gastric cancer.
    Ishigami S; Natsugoe S; Miyazono F; Nakajo A; Tokuda K; Matsumoto M; Okumura H; Douchi T; Hokita S; Aikou T
    Anticancer Res; 2006; 26(3B):2467-72. PubMed ID: 16821634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer.
    Koga F; Kageyama Y; Kawakami S; Fujii Y; Hyochi N; Ando N; Takizawa T; Saito K; Iwai A; Masuda H; Kihara K
    J Urol; 2004 Mar; 171(3):1080-4. PubMed ID: 14767275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.
    Lo SS; Wu CW; Chi CW; Li AF; Chen JH; Lui WY
    Hepatogastroenterology; 2005; 52(66):1902-4. PubMed ID: 16334803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage infiltration and angiogenesis in endometrial cancer.
    Hashimoto I; Kodama J; Seki N; Hongo A; Miyagi Y; Yoshinouchi M; Kudo T
    Anticancer Res; 2000; 20(6C):4853-6. PubMed ID: 11205231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranodal antitumor immunocyte infiltration in node-negative gastric cancers.
    Ishigami S; Natsugoe S; Hokita S; Xiangming C; Aridome K; Iwashige H; Tokuda K; Nakajo A; Miyazono F; Aikou T
    Clin Cancer Res; 2000 Jul; 6(7):2611-7. PubMed ID: 10914701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer.
    Funada Y; Noguchi T; Kikuchi R; Takeno S; Uchida Y; Gabbert HE
    Oncol Rep; 2003; 10(2):309-13. PubMed ID: 12579264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.
    Shimura S; Yang G; Ebara S; Wheeler TM; Frolov A; Thompson TC
    Cancer Res; 2000 Oct; 60(20):5857-61. PubMed ID: 11059783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
    Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
    Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.